BP8 Insider Trading

Insider Ownership Percentage: 49.66%
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

BPH Global Insider Trading History Chart

This chart shows the insider buying and selling history at BPH Global by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BPH Global Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 07/18/2023 01:08 PM ET

This chart shows the closing price history over time for BP8 up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

BPH Global Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/7/2023Matthew LeonardInsiderIssued4,166,667A$0.00A$8,333.33
See Full Table

SEC Filings (Institutional Ownership Changes) for BPH Global (ASX:BP8)

0.97% of BPH Global stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Malaysia. Its products include Caulerpa Lentillifera, a sea grape extract; Dendrobium Officinale Kimura et Migo, an orchid; Resina, a Daemonorops Draco Blume extract; and Cannabis Sativa, an industrial hemp. The company was formerly known as Stemcell United Limited and changed its name to BPH Global Ltd in June 2023. BPH Global Ltd was incorporated in 1984 and is headquartered in Melbourne, Australia.
Read More on BPH Global

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A



Average Volume


Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of BPH Global?

BPH Global's top insider shareholders include:
  1. Matthew Leonard (Insider)
Learn More about top insider investors at BPH Global.